A018620 logo

WooGene B&G Co., Ltd Stock Price

KOSDAQ:A018620 Community·₩17.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A018620 Share Price Performance

₩0
-4775.00 (-100.00%)
₩0
-4775.00 (-100.00%)
Price ₩0

A018620 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

2 Risks
0 Rewards

WooGene B&G Co., Ltd Key Details

₩54.7b

Revenue

₩38.1b

Cost of Revenue

₩16.6b

Gross Profit

₩18.7b

Other Expenses

-₩2.1b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-369.96
30.34%
-3.90%
45.0%
View Full Analysis

About A018620

Founded
1977
Employees
99
CEO
Seokjin Kang
WebsiteView website
www.woogenebng.com

WooGene B&G Co., Ltd. engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally. It offers antibiotic, vaccine, nutrient, anti-inflammation, metabolic stimulant, and iron supplement products for swine, poultry, cattle, aquatic animals, companion animals, and raw materials, as well as operates vaccine research center. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Hwaseong-si, South Korea.

Recent A018620 News & Updates

Recent updates

No updates